NNVC - NanoViricides, Inc.
NanoViricides, Inc. , a nano-biopharmaceutical research and development company, discovers, develops, and commercializes drugs for the treatment of viral infections. The company develops Human Coronavirus Program for COVID-19 seasonal coronavirus affliction; HerpeCide Dermal Topical and Eye Drops for the treatment of shingles, PHN, chickenpox, herpes, recurrent herpes labialis, genital herpes, and ocular herpes keratitis; and HerpeCide IntraOcular Injection for viral acute retinal necrosis The company also develops FluCide Broad-Spectrum Anti-Influenza nanoviricide, which is injectable for hospitalized patients and oral for outpatients; Nanoviricide eye drops for viral diseases of the external eye; DengueCide for treatment of various types of Dengue viruses; and HIVCide, an escape-resistant anti-HIV nanoviricide.
As of May 15, 2026: spot at $1.48, ATM IV 24.8%, net GEX $1.5K.
- Sector
- Healthcare
- Industry
- Biotechnology
- Market Cap
- $30.7M
- Beta
- 1.54
- 52-Week Range
- 0.85-2.23
- CEO
- Anil R. Diwan
- Employees
- 7
- IPO Date
- Oct 26, 2005
- Exchange
- AMEX
What NNVC Looks Like to Options Traders Today
IV rank of 1.4% is subdued relative to the 1-year history, conditions that typically favor premium-buying or long-volatility structures (debit spreads, calendar spreads, long straddles); positive net gamma exposure ($1.5K) means dealers hedge against trend, damping realized volatility and biasing price toward heavy-OI strikes.
What This Page Covers
The NNVC overview links into per-metric analysis views: max pain, gamma exposure, volatility skew, expected move, options chain, open interest history, and aggregate Greeks. Microstructure data is available on short interest, short volume, fail-to-deliver, and market structure. Corporate data is on fundamentals, earnings, analyst ratings, and insider trading.
Frequently asked NNVC overview questions
- What is NNVC?
- NNVC is the ticker symbol for NanoViricides, Inc., a listed security. NanoViricides, Inc. , a nano-biopharmaceutical research and development company, discovers, develops, and commercializes drugs for the treatment of viral infections. Listed on AMEX. NNVC is the equity ticker shown on this page; equity options traders use the security for directional, volatility, and income strategies via the listed options chain.
- What does the NNVC options snapshot look like today?
- As of May 15, 2026, the NNVC options snapshot shows spot at $1.48, ATM IV 24.8%, IV rank 1.4%, net GEX $1.5K, expected move 7.11%. The full options chain, Greeks by strike and expiration, per-strike open-interest distribution, dealer gamma and delta exposure, and the volatility skew surface are linked from this overview page. Each per-metric route refreshes once per trading session and reflects the most recent close-of-business listed-options state.
- What are NNVC's key statistics?
- NanoViricides, Inc. (NNVC) carries a market capitalization of $30.7M, beta of 1.54 relative to the broader market, 52-week range of 0.85-2.23. Full income statement, balance sheet, cash flow, and TTM ratio history is on the per-ticker fundamentals page; daily price history and 52-week levels are accessible from the same view. These structural inputs frame how the options market prices implied volatility around earnings windows and capital events.
- What sector or industry does NNVC belong to?
- NanoViricides, Inc. operates in the Healthcare sector, in the Biotechnology industry. Sector classification affects how the ticker correlates with sector ETFs, how it reacts to macro factors like rate moves and commodity prices, and how its options pricing compares to sector peers. Compare NNVC's implied volatility and skew against sector benchmarks to gauge whether the options market is pricing single-name or systemic risk relative to the broader peer group.
- How current is the NNVC data on this page?
- The options snapshot above is dated May 15, 2026 and refreshes once per session, with all per-strike Greeks and exposure aggregates recomputed at the daily close. Company-profile fields (sector, industry, market cap, P/E, IPO date) refresh from the vendor feed nightly. Financials and earnings refresh as 10-K and 10-Q filings are parsed (typically within several business days of the actual report). FINRA microstructure data refreshes on the source's cadence (daily for short volume, bi-monthly for short interest, weekly for the OTC volume file, twice-monthly for SEC FTD).